{"DataElement":{"publicId":"5985545","version":"1","preferredName":"Treatment Cohort Study 9898 Code","preferredDefinition":"The code that represents the information pertaining to protocol 9898 in which subsets of a defined population are identified.","longName":"TX_COH_SDY_9898_CD","context":"Theradex","contextVersion":"1","DataElementConcept":{"publicId":"2497526","version":"1","preferredName":"Treatment Cohort Study","preferredDefinition":"Information pertaining to studies in which subsets of a defined population are identified. These groups may or may not be exposed to factors hypothesized to influence the probability of the occurrence of a particular disease or other outcome. Cohorts are defined populations which, as a whole, are followed in an attempt to determine distinguishing subgroup characteristics.","longName":"TX_COHORT_STDY","context":"DCP","contextVersion":"1","ObjectClass":{"publicId":"2416951","version":"1","preferredName":"Therapy","preferredDefinition":"An action or administration of therapeutic agents to produce an effect that is intended to alter the course of a pathologic process.","longName":"C15368","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Therapy","conceptCode":"C15368","definition":"An action or administration of therapeutic agents to produce an effect that is intended to alter the course of a pathologic process.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":"NCI Thesaurus","workflowStatus":"RELEASED","registrationStatus":"Application","id":"02DBEE3F-243E-103A-E044-0003BA3F9857","latestVersionIndicator":"Yes","beginDate":"2005-10-12","endDate":null,"createdBy":"SHIDED","dateCreated":"2005-10-12","modifiedBy":"ONEDATA","dateModified":"2005-10-12","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"Property":{"publicId":"2497524","version":"1","preferredName":"Cohort Study","preferredDefinition":"Studies in which subsets of a defined population are identified. These groups may or may not be exposed to factors hypothesized to influence the probability of the occurrence of a particular disease or other outcome. Cohorts are defined populations which, as a whole, are followed in an attempt to determine distinguishing subgroup characteristics.","longName":"C15208","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Cohort Study","conceptCode":"C15208","definition":"A research study that compares a particular outcome (such as lung cancer) in groups of individuals who are alike in many ways but differ by a certain characteristic (for example, female nurses who smoke compared with those who do not smoke).","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":"NCI Thesaurus","workflowStatus":"RELEASED","registrationStatus":"Application","id":"191BBE49-FC9E-4C77-E044-0003BA3F9857","latestVersionIndicator":"Yes","beginDate":"2006-07-21","endDate":null,"createdBy":"MAESKEB","dateCreated":"2006-07-21","modifiedBy":"ONEDATA","dateModified":"2006-07-21","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"ConceptualDomain":{"publicId":"2008538","version":"1","preferredName":"Therapies","preferredDefinition":"actions or administration of therapeutic agents to produce an effect that is intended to alter the course of a pathologic process (NCI).","longName":"TX","context":"CTEP","contextVersion":"2.31","origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"B214D04D-9F05-1CA5-E034-0003BA12F5E7","latestVersionIndicator":"Yes","beginDate":"2002-12-18","endDate":null,"createdBy":"MSUPLEY","dateCreated":"2002-12-18","modifiedBy":"SBR","dateModified":"2003-10-29","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"191BBE49-FCAF-4C77-E044-0003BA3F9857","latestVersionIndicator":"Yes","beginDate":"2006-07-21","endDate":null,"createdBy":"MAESKEB","dateCreated":"2006-07-21","modifiedBy":"SOKKERL","dateModified":"2017-05-10","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"ValueDomain":{"publicId":"5985544","version":"1","preferredName":"9898 Cohort Code","preferredDefinition":"A group of individuals, identified by a common characteristic._A symbol or combination of symbols which is assigned to the members of a collection.","longName":"5985544v1.0","context":"Theradex","contextVersion":"1","type":"Enumerated","dataType":"CHARACTER","minLength":null,"maxLength":"200","minValue":null,"maxValue":null,"decimalPlace":null,"PermissibleValues":[{"value":"SG02","valueDescription":"Cohort A - EGFR T790M negative   no 3rd generation anti-EGFR","ValueMeaning":{"publicId":"5985546","version":"1","preferredName":"Cohort A - EGFR T790M negative   no 3rd generation anti-EGFR","longName":"5985546","preferredDefinition":"Cohort A - EGFR T790M negative   no 3rd generation anti-EGFR","context":"NCIP","contextVersion":"1","Concepts":[],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"5AAC1DD5-1FA2-39E4-E053-F662850AD762","latestVersionIndicator":"Yes","beginDate":"2017-10-03","endDate":null,"createdBy":"SOKKERL","dateCreated":"2017-10-03","modifiedBy":"SENTINEL","dateModified":"2018-03-22","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"5AAC1DD5-1FBB-39E4-E053-F662850AD762","beginDate":"2017-10-03","endDate":null,"createdBy":"SOKKERL","dateCreated":"2017-10-03","modifiedBy":"ONEDATA","dateModified":"2017-10-03","deletedIndicator":"No"},{"value":"SG03","valueDescription":"Cohort B - EGFR T790M negative - prior 3rd generation anti-EGFR","ValueMeaning":{"publicId":"5985547","version":"1","preferredName":"Cohort B - EGFR T790M negative - prior 3rd generation anti-EGFR","longName":"5985547","preferredDefinition":"Cohort B - EGFR T790M negative - prior 3rd generation anti-EGFR","context":"NCIP","contextVersion":"1","Concepts":[],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"5AAC1DD5-1FC5-39E4-E053-F662850AD762","latestVersionIndicator":"Yes","beginDate":"2017-10-03","endDate":null,"createdBy":"SOKKERL","dateCreated":"2017-10-03","modifiedBy":"SBR","dateModified":"2018-01-19","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"5AAC1DD5-1FDE-39E4-E053-F662850AD762","beginDate":"2017-10-03","endDate":null,"createdBy":"SOKKERL","dateCreated":"2017-10-03","modifiedBy":"ONEDATA","dateModified":"2017-10-03","deletedIndicator":"No"},{"value":"SG04","valueDescription":"Cohort C - EGFR T790M positive - prior 3rd generation anti-EGFR","ValueMeaning":{"publicId":"5985548","version":"1","preferredName":"Cohort C - EGFR T790M positive - prior 3rd generation anti-EGFR","longName":"5985548","preferredDefinition":"Cohort C - EGFR T790M positive - prior 3rd generation anti-EGFR","context":"NCIP","contextVersion":"1","Concepts":[],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"5AAC1DD5-1FE8-39E4-E053-F662850AD762","latestVersionIndicator":"Yes","beginDate":"2017-10-03","endDate":null,"createdBy":"SOKKERL","dateCreated":"2017-10-03","modifiedBy":"SBR","dateModified":"2018-01-19","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"5AAC1DD5-2001-39E4-E053-F662850AD762","beginDate":"2017-10-03","endDate":null,"createdBy":"SOKKERL","dateCreated":"2017-10-03","modifiedBy":"ONEDATA","dateModified":"2017-10-03","deletedIndicator":"No"},{"value":"SG05","valueDescription":"Cohort D - EGFR EXON 20 insertion","ValueMeaning":{"publicId":"5985549","version":"1","preferredName":"Cohort D - EGFR EXON 20 insertion","longName":"5985549","preferredDefinition":"Cohort D - EGFR EXON 20 insertion","context":"NCIP","contextVersion":"1","Concepts":[],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"5AAC1DD5-200B-39E4-E053-F662850AD762","latestVersionIndicator":"Yes","beginDate":"2017-10-03","endDate":null,"createdBy":"SOKKERL","dateCreated":"2017-10-03","modifiedBy":"SBR","dateModified":"2018-01-19","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"5AAC1DD5-2024-39E4-E053-F662850AD762","beginDate":"2017-10-03","endDate":null,"createdBy":"SOKKERL","dateCreated":"2017-10-03","modifiedBy":"ONEDATA","dateModified":"2017-10-03","deletedIndicator":"No"},{"value":"SG06","valueDescription":"Cohort E - EGFR-mutant NSCLC - progressed on first-line AZD9291","ValueMeaning":{"publicId":"6596830","version":"1","preferredName":"Cohort E - EGFR-mutant NSCLC - progressed on first-line AZD9291","longName":"6596830","preferredDefinition":"Cohort E - EGFR-mutant NSCLC - progressed on first-line AZD9291","context":"NCIP","contextVersion":"1","Concepts":[],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"7D66C0DC-F22A-15D6-E053-F662850A1AD2","latestVersionIndicator":"Yes","beginDate":"2018-12-19","endDate":null,"createdBy":"TAYLORT","dateCreated":"2018-12-19","modifiedBy":"ONEDATA","dateModified":"2018-12-19","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"7D66C0DC-F243-15D6-E053-F662850A1AD2","beginDate":"2018-12-19","endDate":null,"createdBy":"TAYLORT","dateCreated":"2018-12-19","modifiedBy":"ONEDATA","dateModified":"2018-12-19","deletedIndicator":"No"}],"ConceptualDomain":{"publicId":"2008538","version":"1","preferredName":"Therapies","preferredDefinition":"actions or administration of therapeutic agents to produce an effect that is intended to alter the course of a pathologic process (NCI).","longName":"TX","context":"CTEP","contextVersion":"2.31","origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"B214D04D-9F05-1CA5-E034-0003BA12F5E7","latestVersionIndicator":"Yes","beginDate":"2002-12-18","endDate":null,"createdBy":"MSUPLEY","dateCreated":"2002-12-18","modifiedBy":"SBR","dateModified":"2003-10-29","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"RepresentationTerm":{"publicId":"4386398","version":"1","preferredName":"Cohort Code","preferredDefinition":"A group of individuals, identified by a common characteristic.:A system of numbered categories for representation of data.","longName":"C61512:C25162","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Cohort","conceptCode":"C61512","definition":"A group of individuals, identified by a common characteristic.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"No","displayOrder":"1"},{"longName":"Code","conceptCode":"C25162","definition":"A symbol or combination of symbols which is assigned to the members of a collection.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"FE558C16-1C27-C6A8-E040-BB89AD430BEE","latestVersionIndicator":"Yes","beginDate":"2014-07-16","endDate":null,"createdBy":"MAESKEB","dateCreated":"2014-07-16","modifiedBy":"ONEDATA","dateModified":"2014-07-16","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":"THERADEX:Theradex Systems Inc","workflowStatus":"RELEASED","registrationStatus":"Application","id":"5AABFF36-095F-227C-E053-F662850A86A5","latestVersionIndicator":"Yes","beginDate":"2017-10-03","endDate":null,"createdBy":"SOKKERL","dateCreated":"2017-10-03","modifiedBy":"TAYLORT","dateModified":"2018-12-19","changeDescription":"12/19/18 tt added 1 PV. 11/8/18 TT released/PClark.; 10/3/17 LA 9898 cohort study","administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"ClassificationSchemes":[],"AlternateNames":[],"ReferenceDocuments":[{"name":"Patient Subgroup","type":"Preferred Question Text","description":"Patient Subgroup","url":null,"context":"Theradex"}],"origin":"THERADEX:Theradex Systems Inc","workflowStatus":"RELEASED","registrationStatus":"Application","id":"5AAC1010-5D6A-3D3E-E053-F662850A217A","latestVersionIndicator":"Yes","beginDate":"2017-10-03","endDate":null,"createdBy":"SOKKERL","dateCreated":"2017-10-03","modifiedBy":"SOKKERL","dateModified":"2018-11-13","changeDescription":"10/3/17 LS 9898 cohort study","administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"}}